M1 Kliniken AG (ETR:M12)

Germany flag Germany · Delayed Price · Currency is EUR
14.60
+0.44 (3.11%)
Jul 10, 2025, 9:35 AM CET
-14.37%
Market Cap 262.74M
Revenue (ttm) 339.18M
Net Income (ttm) 16.02M
Shares Out 18.56M
EPS (ttm) 0.85
PE Ratio 16.60
Forward PE 15.73
Dividend 0.50 (3.42%)
Ex-Dividend Date Jul 17, 2025
Volume 4,941
Average Volume 6,138
Open 14.28
Previous Close 14.16
Day's Range 14.28 - 14.62
52-Week Range 12.20 - 18.65
Beta 0.86
RSI 43.61
Earnings Date Jul 30, 2025

About M1 Kliniken AG

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for p... [Read more]

Sector Healthcare
Founded 2007
Employees 199
Stock Exchange Deutsche Börse Xetra
Ticker Symbol M12
Full Company Profile

Financial Performance

In 2024, M1 Kliniken AG's revenue was 339.18 million, an increase of 7.23% compared to the previous year's 316.32 million. Earnings were 16.02 million, an increase of 55.91%.

Financial Statements

News

M1 Kliniken's Q1 2025: 29% EBIT Surge, EPS Hits €0.31

M1 Kliniken AG dazzles with robust Q1 2025 results, driven by strategic growth and ambitious expansion plans. Jetzt den vollständigen Artikel lesen

5 weeks ago - Wallstreet:Online

EQS-News: M1 Kliniken AG: Strong Q1 2025 with 29% EBIT Growth and Earnings per Share of EUR 0.31

EQS-News: M1 Kliniken AG / Key word(s): Quarter Results/Quarterly / Interim Statement M1 Kliniken AG: Strong Q1 2025 with 29% EBIT Growth and Earnings per Share of EUR 0.31 05.06.2025 / 08:30 CET/CEST...

5 weeks ago - Wallstreet:Online

M1 Kliniken: 2024 Earnings Surge & Global Leadership Ambitions

M1 Kliniken AG's 2024 success story unfolds with remarkable earnings growth, driven by a 7% revenue increase and a 30% surge in the Beauty segment, paving the way for ambitious future targets. Jetzt d...

7 weeks ago - Wallstreet:Online

EQS-News: M1 Kliniken AG: Strong Earnings Growth in 2024 – Strategic Focus on Global Market Leadership

EQS-News: M1 Kliniken AG / Key word(s): Annual Report/Dividend M1 Kliniken AG: Strong Earnings Growth in 2024 – Strategic Focus on Global Market Leadership 21.05.2025 / 08:30 CET/CEST The issuer is so...

7 weeks ago - Wallstreet:Online

M1 Kliniken: Strong EBIT & Earnings Surge in 2024 Preview

M1 Kliniken AG has showcased remarkable financial prowess, reporting a significant surge in earnings and strategic expansion across Europe and Australia. Jetzt den vollständigen Artikel lesen

2 months ago - Wallstreet:Online

EQS-News: M1 Kliniken AG publishes preliminary figures for the 2024 financial year: Strong EBIT growth (+70%) and significant increase in earnings per share (+57%)

EQS-News: M1 Kliniken AG / Key word(s): Preliminary Results/Quarter Results M1 Kliniken AG publishes preliminary figures for the 2024 financial year: Strong EBIT growth (+70%) and significant increase...

2 months ago - Wallstreet:Online

EQS-Adhoc: M1 Kliniken AG: HAEMATO AG is reviewing an offer for the sale of its trading segment

EQS-Ad-hoc: M1 Kliniken AG / Key word(s): Investment/Miscellaneous M1 Kliniken AG: HAEMATO AG is reviewing an offer for the sale of its trading segment 01-Apr-2025 / 17:13 CET/CEST Disclosure of an in...

3 months ago - Wallstreet:Online

MPH Health Care: EBIT Hits €55.6M, Equity Soars to €300.3M, 94.85% Ratio

In a year marked by global challenges, MPH Health Care AG has shown remarkable financial resilience, with significant growth in EBIT and equity, while M1 Kliniken AG and CR Energy AG pursue ambitious ...

8 months ago - Wallstreet:Online

M1 Kliniken AG Boosts EBIT by 71% in 2024, Confirms Targets

M1 Kliniken AG has seen a remarkable surge in its financial performance, with a 71% rise in operating profit and a significant boost in its Beauty segment, setting ambitious global expansion goals. Je...

8 months ago - Wallstreet:Online

EQS-News: M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets

EQS-News: M1 Kliniken AG / Key word(s): Quarter Results/9 Month figures M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets 19.11....

8 months ago - Wallstreet:Online

MPH Health Care: H1 2024 EBIT Soars to €75.7M, Equity Hits €325.5M (€76.02/Share)

The preliminary IFRS results for the first half of 2024 reveal a robust financial performance, with significant EBIT growth and equity increases. M1 Kliniken AG expanded its market presence, while CR ...

11 months ago - Wallstreet:Online

M1 Kliniken AG Doubles EBIT, Sees Major Growth in H1 2024

M1 Kliniken AG has showcased impressive growth in early 2024, with sales up by 11.2% and EBIT nearly doubling. The Beauty segment saw a 30.6% sales surge, driving ambitious expansion plans and attract...

11 months ago - Wallstreet:Online

EQS-News: Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024

EQS-News: M1 Kliniken AG / Key word(s): Half Year Results/Quarter Results Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024 03.09.2024 / 08:45 C...

11 months ago - Wallstreet:Online